Response to comment on: “Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis”
Saved in:
| Main Authors: | Danyao Chen, Yuming Sun, Yating Dian, Guangtong Deng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2398874 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis
by: Yating Dian, et al.
Published: (2024-12-01) -
Comment on: “Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis”
by: Muhammed Shabil, et al.
Published: (2024-12-01) -
Efficacy and Tolerability of Tebentafusp in Metastatic Uveal Melanoma: A Real-life Retrospective Multicentre Study
by: Lucille Vitek, et al.
Published: (2024-12-01) -
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp
by: Manuel Rodrigues, et al.
Published: (2024-10-01) -
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
by: Jessica C Hassel, et al.
Published: (2024-06-01)